At CannTrust we are committed to research and innovation, as well as contributing to the growing body of evidence-based research regarding the use and efficacy of cannabis. Our product development teams along with our exclusive pharma partner Apotex are diligently innovating and developing products.
We continue to evolve our patient and medical practitioner education program about Medical Cannabis, and have an industry leading compassionate use program to support patients with financial needs.
Our growing facility is a 430,000-square foot greenhouse in the heart of the Niagara region. The facility is the first of its kind in the Canadian Cannabis industry to be designed and engineered using advanced perpetual growing technology. This facility is one of the largest in North America, with Phase 1 completed and Phase 2 to come on-line in 2019. We continue to expand to ensure we have a continuous supply of quality standardized products and superior customer service.
Dear Valued Customer,
Given the evolving COVID-19 situation across the country, CannTrust is acting in accordance with the guidance for social distancing, where possible. Our customer service department remains open, but due to a reduction in on-site staff you may experience a delay in our response time. As we deal with a critical situation, the safety of our patients, employees, partners, and community at large is of utmost importance for us.
We thank you for your understanding and we hope to return to regular service levels as soon as possible.